Intra-Cellular Shares May Double on Bipolar Depression Data

(Bloomberg) -- Intra-Cellular Therapies Inc. shares could double if the company shows positive data in a pair of late-stage studies in bipolar depression next week, according to two analysts.

Bloomberg Quint

Add BloombergQuint App to Home screen.